COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,760 Articles (22,502 medRxiv, 8,258 bioRxiv)

Most recent first Previous |  Page 442: Articles 4411-4420  | Next

Sensitivity of Rapid Antigen Tests Against SARS-CoV-2 Omicron and Delta Variants
Rao, A., Westbrook, A., Bassit, L., Parsons, R., Fitts, E., Greenleaf, M., McLendon, K. B., Sullivan, J., O'Sick, W. H., Baugh, T., Bowers, H., Frank, F., Wang, E., Le, M., Frediani, J., Roychoudhury, P., Greninger, A. L., Jerris, R., Pollock, N. R., Ortlund, E., Roback, J. D., Lam, W. A., Piantadosi, A.
10.1101/2023.02.09.23285583 — Posted: 2023-02-10
Characteristics and Outcomes of COVID-19 Patients Presumed to be Treated with Sotrovimab in NHS Hospitals in England
Patel, V., Levick, B., Boult, S., Gibbons, D. C., Drysdale, M., Lloyd, E. J., Singh, M., Birch, H. J.
10.1101/2023.02.08.23285654 — Posted: 2023-02-10
Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection in the Netherlands, September to December 2022
Huiberts, A. J., de Gier, B., Hoeve, C. E., de Melker, H. E., Hahne, S. J. M., den Hartog, G., van de Wijgert, J. H. H. M., van den Hof, S., Knol, M. J.
10.1101/2023.02.08.23285643 — Posted: 2023-02-10
Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling
Miyamoto, S., Kuroda, Y., Kanno, T., Ueno, A., Shiwa-Sudo, N., Iwata-Yoshikawa, N., Sakai, Y., Nagata, N., Arashiro, T., Ainai, A., Moriyama, S., Kishida, N., Watanabe, S., Nojima, K., Seki, Y., Mizukami, T., Hasegawa, H., Ebihara, H., Fukushi, S., Takahashi, Y., Maeda, K., Suzuki, T.
10.1101/2023.02.08.23285673 — Posted: 2023-02-10
Clinical severity prediction of COVID-19 admitted patients in Spain: SEMI and REDISSEC cohorts
Martinez-Garcia, M., Garcia-Gutierrez, S., Barrenada Taleb, L., Armananzas, R., Inza, I., Lozano, J. A.
10.1101/2023.02.08.23285589 — Posted: 2023-02-10
Mental health, gender, and care-seeking behavior during the COVID-19 pandemic in Sweden: An exploratory study
Vincze, K., Murphy, G., Barker, M., Gonzalez-Hijon, J., Kähler, A. K., Frans, E. M., Sullivan, P. F., Valdimarsdottir, U. A., Fang, F., Lovik, A.
10.1101/2023.02.08.23285645 — Posted: 2023-02-10
Resilience and social support improve mental health and quality of life in patients with post-COVID-19 syndrome
Galanis, P. A., Katsiroumpa, A., Vraka, I., Kosiara, K., Siskou, O., Konstantakopoulou, O., Katsoulas, T., Gallos, P., Kaitelidou, D.
10.1101/2023.02.07.23285620 — Posted: 2023-02-10
Time warping between main epidemic time series in epidemiological surveillance
Morel, J.-D., Morel, J.-M., Alvarez, L.
10.1101/2023.02.07.23285605 — Posted: 2023-02-10
Interpreting discordant SARS-CoV-2 diagnostic test results
Egbelowo, O. F., Fox, S. J., Gibson, G. C., Meyers, L. A.
10.1101/2023.02.07.23285547 — Posted: 2023-02-10
Association between calcium and vitamin D in geriatric patients hospitalized for Covid-19: Results from the GERIA-COVID study
Alexis, B., ANNWEILER, C., ASFAR, M., Gautier, J., sacco, g., GERIA-COVID study group
10.1101/2023.02.07.23285612 — Posted: 2023-02-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).